Decreased Activity of Plasma ADAMTS13 May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients with Alcoholic Hepatitis

: Background: The pathogenesis of alcoholic hepatitis (AH) remains unclear and the prognosis of severe alcoholic hepatitis (SAH) is very poor. Deficiency of von Willebrand factor (VWF)‐cleaving protease (VWF‐CP/ADAMTS13) results in an increase of the plasma unusually large VWF multimer and leads to...

Full description

Saved in:
Bibliographic Details
Published inAlcoholism, clinical and experimental research Vol. 29; no. s3; pp. 264S - 271S
Main Authors Uemura, Masahito, Matsuyama, Tomomi, Ishikawa, Masatoshi, Fujimoto, Masao, Kojima, Hideyuki, Sakurai, Shinya, Ishii, Sadanobu, Toyohara, Masahisa, Yamazaki, Masaharu, Yoshiji, Hitoshi, Yamao, Jyunichi, Matsumoto, Masanori, Ishizashi, Hiromichi, Fujimura, Yoshihiro, Fukui, Hiroshi
Format Journal Article Conference Proceeding
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.2005
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:: Background: The pathogenesis of alcoholic hepatitis (AH) remains unclear and the prognosis of severe alcoholic hepatitis (SAH) is very poor. Deficiency of von Willebrand factor (VWF)‐cleaving protease (VWF‐CP/ADAMTS13) results in an increase of the plasma unusually large VWF multimer and leads to platelet clumping, which causes microcirculatory disturbance and finally multiorgan failure. The aim of this study was to explore the potential role of ADAMTS13 on the development of liver disturbance and multiorgan failure in AH. Methods: The activity of plasma ADAMTS13 and its clinical correlation were determined in 14 patients with AH, 4 with SAH (Maddrey score, mean 62), and 10 with alcoholic liver cirrhosis (LC). Results: The activity of the plasma ADAMTS13 significantly decreased in patients with AH (mean 59%, p < 0.001), SAH (17%, p < 0.001) and LC (76%, p < 0.02) as compared with the healthy subjects (102%, n = 60). The activity was markedly lower in SAH than in AH (p < 0.02) and LC (p < 0.02). In three nonsurvivors with SAH who had multiorgan failure, it was extremely low (4.5%, 5.0%, and 16.0%, respectively), but in a survivor with SAH it remained mild decrease (44%). In AH, the protease activity increased at the recovery stage (42%→ 75%, p < 0.05). In the univariate analysis, the activity correlated with 10 clinical variables including functional liver capacity, inflammation signs, renal function, and platelet count in patients with AH and SAH. Among these, multivariate analysis showed that serum total bilirubin and C‐reactive protein independently correlated with the protease activity. Conclusion: The activity of plasma ADAMTS13 markedly decreased in SAH in addition to AH. The activity was closely related to hyperbilirubinemia and inflammation signs, and was extremely low in nonsurvivors with SAH and multiorgan failure. The marked decrease of plasma ADAMTS13 may, in part, contribute to not only the progression of liver disturbance in AH, but also the development of multiorgan failure in SAH through microcirculatory disturbance.
Bibliography:istex:FD82F0817D0583F5B2A840C45BDFE543A3F65C37
ArticleID:ACER264S
ark:/67375/WNG-NNDRZ508-Z
Grant support: This work was supported in part by Grants‐in‐Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (YF and MU) and from the Ministry of Health and Welfare of Japan for Blood Coagulation Abnormalities (YF). Masahito Uemura and Yoshihiro Fujimura contributed equally to this study
ISSN:0145-6008
1530-0277
DOI:10.1097/01.alc.0000192326.08931.cb